Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah W Knapp

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cancer Research|December 4, 2012
Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
International Journal of Cancer|October 5, 2019
A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimeraSherwin Jack, Kayalvizhi Madhivanan, Swetha Ramadesikan, et al.
Molecular Cancer Therapeutics|August 26, 2021
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial CarcinomaPaul Rossman, Tanja S Zabka, Audrey Ruple, et al.
Science Translational Medicine|February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative OncologyAmy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cancer Research|December 4, 2012
Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
International Journal of Cancer|October 5, 2019
A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimeraSherwin Jack, Kayalvizhi Madhivanan, Swetha Ramadesikan, et al.
Molecular Cancer Therapeutics|August 26, 2021
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial CarcinomaPaul Rossman, Tanja S Zabka, Audrey Ruple, et al.
Science Translational Medicine|February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative OncologyAmy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Pageof 8